Home » Topics » Disease categories and therapies » Immune

Immune
RSS

VaxGen and EndoBiologics to pursue research of meningitis B vaccine

May 11, 2005

FDA approves Cangene's Vaccinia immune globulin

May 10, 2005

Boostrix receives FDA approval

May 5, 2005

Update on the safety and immunogenicity of recombinant MVA-BN-based vaccines

May 4, 2005

Serono to develop Genmab's HuMax-TAC

May 4, 2005

GlaxoSmithKline to acquire Corixa

May 4, 2005

Isotechnika gets go-ahead for phase IIb kidney transplant study of ISA-247

May 4, 2005

ImmuFact IMP-321 enters phase I/II trials

May 3, 2005

New immunomodulatory agents disclosed by General Atomics

April 27, 2005

A new immunostimulat from intestinal Eimeria

April 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...